Search
Wednesday 15 July 2015
  • :
  • :

Eye-Catching Stocks: Texas Instruments Incorporated (NASDAQ:TXN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Sinclair Broadcast Group Inc (NASDAQ:SBGI)

On Monday, in the course of current trade, Shares of Texas Instruments Incorporated (NASDAQ:TXN), climbed 0.84%, and is now trading at $49.42.

Texas Instruments Incorporated, will webcast its second-quarter 2015 earnings conference call on Wednesday, July 22, at 4:30 p.m. Central time. Kevin March, senior vice president and chief financial officer, and Dave Pahl, vice president and head of Investor Relations, will talk about TI’s financial results and answer questions from the investor audience.

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing.

During an Afternoon trade, Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), climbed 1.83%, and is now trading at $144.26.

BioMarin Pharmaceutical, declared the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for drisapersen for the treatment of Duchenne Muscular Dystrophy amenable to exon 51 skipping. Validation of the MAA confirms that the submission is complete and starts the EMA’s standard review process. Day 120 questions will be received on 22 October 2015, leading to a potential CHMP opinion in the first half of 2016 and a European Commission Decision by the third quarter of 2016.

Drisapersen is an investigational antisense oligonucleotide drug candidate for the treatment of the largest subset of Duchenne muscular dystrophy (DMD) amenable to single exon skipping. Drisapersen induces the skipping of dystrophin exon 51, potentially providing a therapeutic benefit to DMD patients for whom skipping of exon 51 restores the proper dystrophin reading frame, corresponding to about 13% of DMD patients.

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally.

Finally, Sinclair Broadcast Group Inc (NASDAQ:SBGI) , gained 2.31% Monday, hitting its highest level.

Sinclair Broadcast Group, declared the launch date for “Full Measure with Sharyl Attkisson” to debut on Sunday, October 4, 2015. The broadcast will air on Sinclair’s associates nationwide and be accessible on their websites. The 30-minute program, which will be based in Washington, D.C., will focus on investigative journalism and target accountability in the public and private sectors.

“We will pierce secrecy and seek accountability from government, corporations and special interests,” said Ms. Attkisson, host of the broadcast. “We will report on untouchable topics in a fearless way with a team of award winning journalists. We will follow the trail no matter where it leads.”

Sinclair Broadcast Group, Inc., a diversified television broadcasting company, owns and operates, programs, or provides sales services to television stations in the United States. It broadcasts free over-the-air programming, such as network offered programs, news produced locally, local sporting events, programming from program service arrangements, syndicated entertainment programs, and other locally produced programs.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *